Sign in

CIK 0001404281 · Non-accelerated filer<br>Smaller reporting company

Eledon Pharmaceuticals, Inc.

Sign in to watch
Ticker
ELDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
949-238-8090
Business address
19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
Former names
Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
  1. SC 13G/A Stake Amended Statement of Ownership
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G Stake Amended Statement of Ownership
  4. 8-K Event Unregistered share sale
  5. SC 13D/A Stake Beneficial Ownership Report
  6. 8-K Event Bylaws or fiscal year change · Other events
  7. SC 13G Stake Amended Statement of Ownership
  8. SC 13G Stake Amended Statement of Ownership
  9. SC 13G/A Stake Amended Statement of Ownership
  10. SC 13G/A Stake Amended Statement of Ownership
  11. 4 Conversion See Explanation of Responses acquired 1,289,628 shares (conversion)
  12. EFFECT Other Notice of Effectiveness
  13. 424B2 Offering Prospectus
  14. 8-K Event Shareholder vote results
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. UPLOAD Other SEC-generated Letter
  17. 3 Insider Initial Statement of Ownership
  18. S-3 Offering Registration Statement
  19. 8-K Event Bylaws or fiscal year change
  20. DEFA14A Proxy Proxy Materials

Page 13 of 31 · 616 filings